AKBA EBITDA
Akebia Therapeutics Inc · EBITDA
AKBA EBITDA
Latest reported-$18.34Mperiod ending
AKBA TTM EBITDA (-$9.34M → -$18.34M)
TTM EBITDA
High-resolution chart · PNG
AKBA ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -18,339,000 | |
| -5,760,000 | |
| 21,727,000 | |
| 21,232,000 | |
| 11,007,000 | |
| 4,795,000 | |
| -14,314,000 | |
| 3,704,000 | |
| 4,036,000 | |
| 2,728,000 | |
| -8,265,000 | |
| -2,505,000 | |
| -39,553,000 | |
| 4,482,000 | |
| -27,543,000 | |
| -92,702,000 | |
| -96,957,000 | |
| -209,436,000 | |
| -216,756,000 | |
| -216,290,000 | |
| -222,380,000 | |
| -317,635,000 | |
| -311,534,000 | |
| -329,258,000 | |
| -324,354,000 | |
| -209,847,000 | |
| -226,336,000 | |
| -247,790,000 | |
| -229,247,000 | |
| -215,380,000 | |
| -174,040,000 | |
| -75,801,000 | |
| -72,192,000 | |
| -58,762,000 | |
| -79,300,000 | |
| -128,784,000 | |
| -140,863,000 | |
| -154,987,000 | |
| -136,164,000 | |
| -118,283,000 | |
| -101,838,000 | |
| -76,554,000 | |
| -61,317,000 | |
| -51,469,000 | |
| -41,397,000 | |
| -38,367,000 | |
| -37,167,315 | |
| -29,706,644 | |
| -24,169,635 | |
| -16,341,635 | |
| -9,341,038 | |
| -8,464,793 |